Ph- MPNs are associated with driver genes mutations, like JAK2 in nearly 90% of PV patients and in around 50% of all ET and MF patients [32], and CALR, present in about 20%–35% of patients affected by ET and primary MF [33]. This evidence concerns the gene JAK2 and essential thrombocythemia.